Consistently, IRGM polymorphisms have been associated with human diseases including cancer (gastric cancer, renal cell carcinoma, and glioma), infection (tuberculosis and leprosy), autoimmunity (autoimmune thyroid disorders) and inflammatory disorders (CD, non-alcohol fatty liver disease, and chronic periodontitis). Here, IRGM is linked to cancer.